Graphical representation of network meta-analysis: an iconographic support to the complexity of multiple data comparisons

被引：2
作者：
De Vecchis, Renato [1 ]
Ariano, Carmelina [2 ]
Rigopoulos, Angelos [3 ]
Noutsias, Michel [3 ]
机构：
[1] DSB 29 S Gennaro Poveri Hosp, Prevent Cardiol & Rehabil Unit, Via S Gennaro Poveri 25, I-80136 Naples, Italy
[2] Casa Sollievo Sofferenza Hosp, Dept Geriatr, Via Cappuccini 2, I-71013 San Giovanni Rotondo, Italy
[3] Martin Luther Univ Halle Wittenberg, Univ Hosp Halle, Div Cardiol Angiol & Intens Med Care, Midgerman Heart Ctr, Ernst Grube Str 40, D-06120 Halle, Germany
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2019年 / 75卷 / 01期
关键词：
RIVAROXABAN; DABIGATRAN; STROKE; RISK;
D O I：
10.1007/s00228-018-2551-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：131 / 132
页数：2
相关论文
共 9 条
[1]  
Aalbers J, 2010, CARDIOVASC J AFR, V21, P342
[2]   Network Meta-Analysis with Competing Risk Outcomes [J].
Ades, A. E. ;
Mavranezouli, Ifigeneia ;
Dias, Sofia ;
Welton, Nicky J. ;
Whittington, Craig ;
Kendall, Tim .
VALUE IN HEALTH, 2010, 13 (08) :976-983
[3]   Newly Identified Events in the RE-LY Trial [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Reilly, Paul A. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) :1875-1876
[4]   Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation [J].
Graham, David J. ;
Reichman, Marsha E. ;
Wernecke, Michael ;
Hsueh, Hui ;
Izem, Rima ;
Southworth, Mary Ross ;
Wei, Yuqin ;
Liao, Jiemin ;
Goulding, Margie R. ;
Mott, Katrina ;
Chillarige, Yoganand ;
MaCurdy, Thomas E. ;
Worrall, Chris ;
Kelman, Jeffrey A. .
JAMA INTERNAL MEDICINE, 2016, 176 (11) :1662-1671
[5]   Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data [J].
Hernandez, Inmaculada ;
Zhang, Yuting .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (01) :37-47
[6]   Network meta-analysis for indirect treatment comparisons [J].
Lumley, T .
STATISTICS IN MEDICINE, 2002, 21 (16) :2313-2324
[7]   Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation [J].
Noseworthy, Peter A. ;
Yao, Xiaoxi ;
Abraham, Neena S. ;
Sangaralingham, Lindsey R. ;
McBane, Robert D. ;
Shah, Nilay D. .
CHEST, 2016, 150 (06) :1302-1312
[8]   Rivaroxaban-Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study [J].
Patel, Manesh R. .
AMERICAN HEART JOURNAL, 2010, 159 (03) :340-U31
[9]   Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial [J].
Woods, Beth S. ;
Hawkins, Neil ;
Scott, David A. .
BMC MEDICAL RESEARCH METHODOLOGY, 2010, 10
1